首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1619045

医药中间体市场规模、份额、成长分析、按产品、按类别、按应用、按最终用户、按地区 - 行业预测，2024-2031 年

Pharmaceutical Intermediates Market Size, Share, Growth Analysis, By Product, By Category, By Application, By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年12月18日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年医药中间体的全球市场规模为291.8亿美元，从2023年的312.5亿美元成长到2031年的541亿美元，在预测期内（2024-2031年）预计复合年增长率为7.1。

由于医药和化妆品行业的需求不断增长，医药中间体市场正在经历显着增长，因为这些中间体是活性药物成分 (API) 生产的重要原材料。随着人们对高科技治疗和个人化医疗的日益关注，对 API 的需求不断增加，刺激了市场扩张。然而，生物製药相关的高成本以及生产原料药所需的大量资本投资等挑战可能会阻碍成长。但随着新兴市场製造技术的发展和研发投入的加大，市场发展的机会也大大拓展。利用高品质的基础原料，该领域将不断发展，以满足製药和农化製造的多样化需求。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东/非洲
- 海湾合作委员会国家
- 南非
- 其他中东/非洲

竞争资讯

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市场趋势
公司市场占有率分析（2023）
主要企业简介
- 公司简介
- 产品系列分析
- 按细分市场分類的份额分析
- 收益与前一年同期比较（2021-2023）

主要企业简介

BASF SE（Germany）
Sanofi SA（France）
Thermo Fisher Scientific Inc.（US）
Merck KGaA（Germany）
Dishman Carbogen Amcis Ltd.（India）
Evonik Industries AG（Germany）
Arkema Inc.（France）
Lonza Group AG（Switzerland）
Wuxi AppTec Co., Ltd.（China）
Aurobindo Pharma Limited（India）
Lianhe Chemical Technology Co., Ltd.（China）
Cambrex Corporation（US）
Vertellus Holdings LLC（US）
Hovione LLC（Portugal）
Hikal Ltd.（India）
Codexis Inc.（US）
Aceto Corporation（US）
Interchem Corporation（US）
Midas Pharma GmbH（Germany）
Arbiom（US）

结论和建议

简介目录

Product Code: SQMIG35I2111

Global Pharmaceutical Intermediates Market size was valued at USD 29.18 billion in 2022 and is poised to grow from USD 31.25 billion in 2023 to USD 54.1 billion by 2031, growing at a CAGR of 7.1% during the forecast period (2024-2031).

The pharmaceutical intermediates market is witnessing substantial growth, driven by rising demand in the pharmaceutical and cosmetic sectors as these intermediates serve as essential raw materials in active pharmaceutical ingredient (API) production. With the growing focus on high-tech therapies and personalized medicine, the need for APIs is escalating, further fueling market expansion. However, challenges such as high costs associated with biopharmaceuticals and the significant capital investment required for API production could hinder growth. Nevertheless, advancements in manufacturing technologies and increased investment in research and development are poised to unlock considerable opportunities within the market. By leveraging quality basic materials, the sector is set to continue evolving, catering to the diverse needs of drug and pesticide production.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceutical Intermediates market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmaceutical Intermediates Market Segmental Analysis

Global Pharmaceutical Intermediates Market is segmented by product, category, application, end user and region. Based on product, the market is segmented into chemical intermediates, bulk drug intermediates, chiral intermediates, achiral intermediates and custom intermediates. Based on category, the market is segmented into branded drug intermediates and generic drug intermediates. Based on application, the market is segmented into analgesics, anti-inflammatory drug, cardiovascular drugs, anti-diabetic drugs, antimicrobial drugs, anti-cancer drugs and others. Based on end user, the market is segmented into biotech and pharma companies, research laboratory and CMOS/CROS. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pharmaceutical Intermediates Market

The Global Pharmaceutical Intermediates market is significantly driven by the rising prevalence of chronic diseases and the aging demographic across the globe. The World Health Organization (WHO) notes that the number of diabetes cases soared from 108 million in 1980 to 422 million by 2014, and this upward trend persists. Moreover, WHO projects that chronic diseases will surge by 57% by 2020, revealing that a considerable proportion of the population is affected. These alarming statistics underscore the escalating demand for drug formulations aimed at managing chronic conditions, thereby fueling substantial growth in the Pharmaceutical Intermediates market during the forecast period.

Restraints in the Global Pharmaceutical Intermediates Market

One significant restraint affecting the global pharmaceutical intermediates market is the substantial expense linked to acquiring biopharmaceutical drugs. This high financial burden not only limits accessibility for many companies but also restricts their ability to invest in research and development. Additionally, the considerable capital investment necessary for the production of active pharmaceutical ingredients (APIs) further hinders market growth. These financial challenges can deter new entrants and stifle innovation within the industry, ultimately impacting the overall development and supply chain of pharmaceutical intermediates and creating barriers to fulfilling market demand.

Market Trends of the Global Pharmaceutical Intermediates Market

The Global Pharmaceutical Intermediates market is experiencing significant growth driven by the escalating prevalence of chronic cardiovascular diseases, particularly ischemic heart disease (IHD), which is projected to impact over 126 million individuals worldwide. As IHD emerges as the leading cause of death globally, with forecasts suggesting an alarming increase to 1,845 cases per 100,000 individuals by 2030, the demand for pharmaceutical intermediates essential for the production of cardiovascular medications is surging. This trend accentuates the urgent need for innovation in drug formulation and production, positioning pharmaceutical intermediates as a critical sector in addressing rising healthcare costs associated with heart disease.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Analysis
Patent Analysis
Case Study Analysis

Global Pharmaceutical Intermediates Market Size by Product & CAGR (2024-2031)

Market Overview
Chemical Intermediates
Bulk Drug Intermediates
Chiral Intermediates
Achiral Intermediates
Custom Intermediates

Global Pharmaceutical Intermediates Market Size by Category & CAGR (2024-2031)

Market Overview
Branded Drug Intermediates
Generic Drug Intermediates

Global Pharmaceutical Intermediates Market Size by Application & CAGR (2024-2031)

Market Overview
Analgesics
Anti-Inflammatory Drug
Cardiovascular Drugs
Anti-Diabetic Drugs
Antimicrobial Drugs
Anti-Cancer Drugs
Others

Global Pharmaceutical Intermediates Market Size by End User & CAGR (2024-2031)

Market Overview
Biotech and Pharma Companies
Research Laboratory
CMOS/CROS

Global Pharmaceutical Intermediates Market Size & CAGR (2024-2031)

North America (Product, Category, Application, End User)
- USA
- Canada
Europe (Product, Category, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Category, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Category, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Category, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

BASF SE (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dishman Carbogen Amcis Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Evonik Industries AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arkema Inc. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza Group AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wuxi AppTec Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aurobindo Pharma Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lianhe Chemical Technology Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cambrex Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vertellus Holdings LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hovione LLC (Portugal)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hikal Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Codexis Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aceto Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Interchem Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Midas Pharma GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arbiom (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments